Paper26901751
An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human Complement.
Wagemakers A and 8 others. Vector Borne Zoonotic Dis, 2016. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human Complement. Papers, record 26901751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26901751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human Complement.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthropod Proteins | Major topic |
| Borrelia burgdorferi Group | Major topic |
| Ixodes | Major topic |
| Salivary Glands | Major topic |
| Salivary Proteins and Peptides | Major topic |
| Animals | |
| Arachnid Vectors | |
| Complement Pathway, Mannose-Binding Lectin | |
| Humans | |
| Lyme Disease |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39345262 | Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39345262 | PubMed |
| 35372098 | Host Immune Responses to Salivary Components - A Critical Facet of Tick-Host Interactions. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35372098 | PubMed |
| 35283489 | Prevention of tick-borne diseases: challenge to recent medicine. | Biologia (Bratisl) | 2022 | https://conductscience.org/library/papers/35283489 | PubMed |
| 34722347 | Immunomodulatory Proteins in Tick Saliva From a Structural Perspective. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34722347 | PubMed |
| 34344917 | Probing an Ixodes ricinus salivary gland yeast surface display with tick-exposed human sera to identify novel candidates for an anti-tick vaccine. | Sci Rep | 2021 | https://conductscience.org/library/papers/34344917 | PubMed |
| 33916367 | Vertebrate Responses against Arthropod Salivary Proteins and Their Therapeutic Potential. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33916367 | PubMed |
| 33801255 | The Brilliance of Borrelia: Mechanisms of Host Immune Evasion by Lyme Disease-Causing Spirochetes. | Pathogens | 2021 | https://conductscience.org/library/papers/33801255 | PubMed |
| 33673273 | Changing the Recipe: Pathogen Directed Changes in Tick Saliva Components. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/33673273 | PubMed |
| 33289684 | Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes. | Curr Issues Mol Biol | 2021 | https://conductscience.org/library/papers/33289684 | PubMed |
| 33289683 | Interactions Between Ticks and Lyme Disease Spirochetes. | Curr Issues Mol Biol | 2021 | https://conductscience.org/library/papers/33289683 | PubMed |
| 33208766 | A combined transcriptomic approach to identify candidates for an anti-tick vaccine blocking B. afzelii transmission. | Sci Rep | 2020 | https://conductscience.org/library/papers/33208766 | PubMed |
| 33187012 | Acquired tick resistance: The trail is hot. | Parasite Immunol | 2021 | https://conductscience.org/library/papers/33187012 | PubMed |
| 33072132 | Tick Salivary Compounds for Targeted Immunomodulatory Therapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33072132 | PubMed |
| 32083019 | New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32083019 | PubMed |
| 31953560 | Novel targets and strategies to combat borreliosis. | Appl Microbiol Biotechnol | 2020 | https://conductscience.org/library/papers/31953560 | PubMed |
| 31297067 | The Use of Tick Salivary Proteins as Novel Therapeutics. | Front Physiol | 2019 | https://conductscience.org/library/papers/31297067 | PubMed |
| 31088506 | Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission. | Parasit Vectors | 2019 | https://conductscience.org/library/papers/31088506 | PubMed |
| 31062185 | Tick saliva and its role in pathogen transmission. | Wien Klin Wochenschr | 2023 | https://conductscience.org/library/papers/31062185 | PubMed |
| 30723261 | The role of Mannose Binding Lectin in the immune response against Borrelia burgdorferi sensu lato. | Sci Rep | 2019 | https://conductscience.org/library/papers/30723261 | PubMed |
| 28848718 | Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and Anaplasma phagocytophilum Infection. | Front Cell Infect Microbiol | 2017 | https://conductscience.org/library/papers/28848718 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26901751
GET https://conductscience.org/api/papers/v1/26901751/cited_by?page=2